Ritsuko Seki

973 total citations
48 papers, 647 citations indexed

About

Ritsuko Seki is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ritsuko Seki has authored 48 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 15 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Ritsuko Seki's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Ritsuko Seki is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Ritsuko Seki collaborates with scholars based in Japan, United States and Finland. Ritsuko Seki's co-authors include Takashi Okamura, Michio Sata, Koji Nagafuji, Yoshiyuki Sakaki, Tsuyoshi Hamada, Kazuaki Yakushiji, Koichi Osaki, Koichi Ohshima, Hiroyuki Sasaki and Takayuki Ueda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Development.

In The Last Decade

Ritsuko Seki

45 papers receiving 635 citations

Peers

Ritsuko Seki
Evi Regitz Germany
Takeki Mitsui Japan
S. Saks United States
S L Perkins United States
H Yamada Japan
J. Kimble Frazer United States
Satoshi Shiraishi Japan
R. Piccinno Italy
Benjamin E. Rich United States
Qinglin Ou United States
Evi Regitz Germany
Ritsuko Seki
Citations per year, relative to Ritsuko Seki Ritsuko Seki (= 1×) peers Evi Regitz

Countries citing papers authored by Ritsuko Seki

Since Specialization
Citations

This map shows the geographic impact of Ritsuko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritsuko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritsuko Seki more than expected).

Fields of papers citing papers by Ritsuko Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritsuko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritsuko Seki. The network helps show where Ritsuko Seki may publish in the future.

Co-authorship network of co-authors of Ritsuko Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Ritsuko Seki. A scholar is included among the top collaborators of Ritsuko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritsuko Seki. Ritsuko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ozawa, Hidetoshi, Kensuke Sasaki, Yuichiro Semba, et al.. (2020). Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion. International Journal of Hematology. 113(2). 285–289. 2 indexed citations
2.
Nakamura, Takayuki, Hidetoshi Ozawa, Maki Yamaguchi, et al.. (2020). Successful correction of factor V deficiency of patient‐derived iPSCs by CRISPR/Cas9‐mediated gene editing. Haemophilia. 26(5). 826–833. 8 indexed citations
3.
Mizuno, Shinichi, Hidetoshi Ozawa, Takayuki Nakamura, et al.. (2019). CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs. International Journal of Hematology. 111(2). 225–233. 22 indexed citations
4.
Arakawa, Fumiko, Takayuki Nakamura, Ritsuko Seki, et al.. (2019). Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation. International Journal of Hematology. 110(4). 506–511. 6 indexed citations
5.
Kawamoto, Keisuke, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2017). Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified. European Journal Of Haematology. 98(5). 459–466. 9 indexed citations
6.
Nozawa, Yoshihiro, et al.. (2014). Serum Free Light Chain Only Myeloma with Cytoplasmic IgM. SHILAP Revista de lepidopterología. 2014. 1–5. 2 indexed citations
7.
Seki, Ritsuko, Sho‐ichi Yamagishi, Takanori Matsui, et al.. (2013). Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties. Biochemical and Biophysical Research Communications. 431(4). 693–697. 19 indexed citations
8.
Sasaki, Ken‐ichiro, Takafumi Ueno, Ritsuko Seki, et al.. (2013). Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients. Atherosclerosis. 227(2). 275–282. 36 indexed citations
9.
Matsueda, Satoko, Nobukazu Komatsu, Ken-Ichi Kusumoto, et al.. (2013). Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases. Developmental & Comparative Immunology. 41(1). 68–76. 14 indexed citations
10.
Nomura, Kei, Takayuki Nakamura, Ritsuko Seki, et al.. (2012). Successful treatment of small cell variant anaplastic large cell lymphoma with allogeneic peripheral blood stem cell transplantation, and review of the literature. International Journal of Hematology. 97(1). 139–143. 3 indexed citations
11.
12.
Nakamura, Takayuki, Kei Nomura, Ritsuko Seki, et al.. (2012). Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute. International Journal of Hematology. 96(5). 657–663. 15 indexed citations
13.
Seki, Ritsuko, Koichi Ohshima, Tomoaki Fujisaki, et al.. (2009). Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. Annals of Oncology. 21(4). 833–841. 25 indexed citations
14.
Mitsuyama, Keiichi, Akira Andoh, Junya Masuda, et al.. (2008). Mobilization of Bone Marrow Cells by Leukocytapheresis in Patients With Ulcerative Colitis. Therapeutic Apheresis and Dialysis. 12(4). 271–277. 12 indexed citations
15.
Kanaji, Taisuke, Koichi Oshima, Ritsuko Seki, et al.. (2008). Periostin and bone marrow fibrosis. International Journal of Hematology. 88(1). 57–63. 51 indexed citations
16.
Seki, Ritsuko, Koichi Osaki, Kazuaki Yakushiji, et al.. (2006). Promyelocytic Crisis of Chronic Myelogenous Leukaemia during Imatinib Mesylate Treatment. Acta Haematologica. 117(4). 191–196. 3 indexed citations
17.
Seki, Ritsuko, Takashi Okamura, Toru Maruyama, et al.. (2005). Quantitative studies on the impaired filterability of erythrocytes from patients with liver cirrhosis. 19(1). 50–59.
18.
Seki, Ritsuko, Koichi Ohshima, Kazuaki Yakushiji, et al.. (2004). Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis: A Case Report. International Journal of Hematology. 80(5). 428–431. 10 indexed citations
19.
Natsuka, Shunji, et al.. (2001). Molecular Cloning and Expression of Caenorhabditis elegans ERp57-Homologue with Transglutaminase Activity. The Journal of Biochemistry. 130(6). 731–735. 17 indexed citations
20.
Matsuzaki, Goro, et al.. (1993). Extensive N nucleotide addition in junctional region of T cell receptor Vγ5 genes rearranged in fetal liver‐derived thymocytes in radiation chimera mice. European Journal of Immunology. 23(12). 3345–3349. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evi Regitz Breakdown of academic impact, for papers by Takeki Mitsui Breakdown of academic impact, for papers by S. Saks Breakdown of academic impact, for papers by S L Perkins Breakdown of academic impact, for papers by H Yamada Breakdown of academic impact, for papers by J. Kimble Frazer Breakdown of academic impact, for papers by Satoshi Shiraishi Breakdown of academic impact, for papers by R. Piccinno Breakdown of academic impact, for papers by Benjamin E. Rich Breakdown of academic impact, for papers by Qinglin Ou
Rankless by CCL
2026